Fidelis Pharmaceuticals is Other Consumer Non-Durables in United States that focus on pharmaceutical grade business. Founded in 2016. They cover business area such as developer, manufacturer, pharmaceutical formulation, high-quality animal welfare solution, development, marketing, pharmaceutical grade extend-release buprenorphine, post-procedural pain, laboratory mouse, reliable, cgmp-quality product, veterinary need.
2016
( 8 years old in 2024 )
Pharmaceutical Grade
-
675 Highway One
Suite B113
North Brunswick, NJ 08902
United States
Private
developermanufacturerpharmaceutical formulationhigh-quality animal welfare solutiondevelopmentmarketingpharmaceutical grade extend-release buprenorphinepost-procedural painlaboratory mousereliable, cgmp-quality productveterinary need
* We use standard office opening hours in near Fidelis Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Fidelis Pharmaceuticals is Other Consumer Non-Durables business from United States that founded in 2016 (8 years old in 2024), Fidelis Pharmaceuticals business is focusing on Pharmaceutical Grade.
Fidelis Pharmaceuticals headquarter office and corporate office address is located in 675 Highway One Suite B113 North Brunswick, NJ 08902 United States.
Fidelis Pharmaceuticals was founded in United States.
In 2024, Fidelis Pharmaceuticals is currently focus on pharmaceutical grade sector.
Above is snippet of Google Trends for "pharmaceutical grade" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Fidelis Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
